View from the Thoraxcenter: ESC 25 Late-break...

In this Redcliffe Cardiology NVM reflections episode, Prof Nicolas Van Mieghem cuts through the noise from TCT 2025. Tune in to hear what the SELUTION trials mean for drug-coated balloons in de novo disease and ISR, why cost and sizing matter in calcium modification, how PE throm ...  Show more

At TCT 2025, Dr Nadira Hamid (Minneapolis Heart Institute, US) and Dr. Rahul P. Sharma (Stanford University, US) review the late-breaking trial data shaping the future of structural heart disease. The discussion highlights real-world results from TRISCEND and TRILUMINATE in tricu ...  Show more

Join our hosts Can Gollmann-Tepeköylü and Miia L Lehtinen for their late-breaking trials highlights presented at the 37th EACTS Annual Meeting in Vienna, including: 

In this special ESC Congress episode of Eagle’s Eye View, Drs. Deepak Bhatt, Payal Kohli, and Philippe Gabriel Steg discuss highlights from Day 1 of the ESC Congress 2022: late-breaking science and featured clinical research, including SECURE, ENTRIGUE, TIME, and REDUCE-IT. 

In this episode, podcast cohost Dr. Ashwin Parihar and guest Dr. Jessica Porembka, chair of the RSNA education exhibit awards committee, highlight several standout educational and scientific presentations at RSNA 2024 and discuss larger trends in education an ...

Listen as we discuss the highly-awaited ESOPEC trial, which examines treatment regimens for esophageal and EGJ adenocarcinoma. Wildly impress your thoracic attendings or peers with your nuanced knowledge! FLOT who? You’ll know. Pull out the paper and listen along!Learning Objecti ...  Show more